Nucleoprotein (265-273)

Nucleoprotein (265-273) is a synthetic peptide fragment corresponding to amino acid residues 265 to 273 of a nucleoprotein sequence, typically derived from viral or microbial sources. As a defined peptide epitope, it holds particular significance in immunological research and molecular biology due to its role in mimicking a specific region of a native nucleoprotein antigen. Its well-characterized sequence enables researchers to investigate antigenic determinants, T cell recognition, and antibody specificity with high precision. The biochemical stability and defined structure of this peptide make it an essential tool for dissecting protein-protein interactions and immune responses at the molecular level.

Epitope Mapping: In immunology laboratories, the 265-273 peptide fragment is routinely employed for epitope mapping studies. By exposing immune cells or antibodies to this defined sequence, researchers can delineate the precise regions of the nucleoprotein that are recognized by the adaptive immune system. Such mapping is critical for understanding host-pathogen interactions, guiding vaccine design, and identifying immunodominant regions that elicit robust T cell or antibody responses.

T Cell Activation Assays: The peptide serves as a reliable reagent in T cell activation and proliferation assays. Its defined sequence allows for controlled stimulation of antigen-specific T cell populations in vitro, facilitating the assessment of cellular immune responses. This application is particularly valuable for evaluating peptide-MHC binding affinities, studying T cell receptor specificity, and screening for immunogenic epitopes relevant to infectious disease or immunotherapy research.

Antibody Specificity Testing: Researchers utilize this nucleoprotein-derived peptide to assess the specificity and cross-reactivity of monoclonal or polyclonal antibodies. By incorporating the peptide into enzyme-linked immunosorbent assays (ELISA), western blots, or other immunodetection platforms, scientists can determine whether antibodies recognize the target epitope, thereby validating antibody reagents or characterizing immune sera. This approach supports the development of highly specific diagnostic reagents and enhances the reliability of immunoassays.

Peptide-Based Vaccine Research: The 265-273 region of nucleoproteins is often explored as a candidate epitope in peptide-based vaccine development. Its ability to be synthesized with high purity and presented in a consistent manner enables systematic evaluation of its immunogenic potential. Researchers can incorporate the peptide into immunization protocols to assess its capacity to induce targeted immune responses, providing valuable data for rational vaccine design and optimization of epitope-based immunogens.

Protein-Protein Interaction Studies: Beyond immunology, the peptide is also valuable in probing protein-protein interactions involving nucleoprotein domains. By serving as a molecular probe or competitive inhibitor in binding assays, it aids in elucidating the interaction interfaces between nucleoproteins and their cellular partners. Such studies contribute to a deeper understanding of viral replication mechanisms, host-pathogen dynamics, and the structural basis of nucleoprotein function within complex biological systems.

1. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

2. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII